Publications

Ruth Dubin, Rajat Deo, Yue Ren, Jianqiao Wang, Zihe Zheng, Haochang Shou, Alan Go, Afshin Parsa, James Lash, Mahboob Rahman, Chi-yuan Hsu, Matthew Weir, Jing Chen, Amanda Anderson, Morgan Grams, Aditya Surapaneni, Josef Coresh, Hongzhe Lee, Paul Kimmel, Ramachandran Vasan, Harold Feldman, Mark Segal, Peter Ganz (2023). Proteomics of CKD Progression in the Chronic Renal Insufficiency Cohort. Accepted in Nature Communication.

Rajat Deo, Ruth F Dubin, Yue Ren, Ashwin C Murthy, Jianqiao Wang, Haotian Zheng, Zihe Zheng, Harold Feldman, Haochang Shou, Josef Coresh, others (2023). Proteomic cardiovascular risk assessment in chronic kidney disease. European Heart Journal.

Zhen Miao, Jianqiao Wang, Kernyu Park, Da Kuang, Junhyong Kim (2023). Model-based compound hypothesis testing for snATAC-seq data with PACS. bioRxiv.

Jianqiao Wang, Sai Li, Hongzhe Li (2023). A Regression-based Approach to Robust Estimation and Inference for Genetic Covariance. Journal of the American Statistical Association.

Jianqiao Wang, Wanjie Wang, Hongzhe Li (2022). Sparse Block Signal Detection and Identification for Shared Cross-Trait Association Analysis. Annals of Applied Statistics.

Jianqiao Wang, Hongzhe Li (2022). Estimation of genetic correlation with summary association statistics. Biometrika.

Chi-yuan Hsu, Wei Yang, Rishi V. Parikh, Amanda H. Anderson, Teresa K. Chen, Debbie L. Cohen, Jiang He, Madhumita J. Mohanty, James P. Lash, Katherine T. Mills, Anthony N. Muiru, Afshin Parsa, Milda R. Saunders, Tariq Shafi, Raymond R. Townsend, Sushrut S. Waikar, Jianqiao Wang, Myles Wolf, Thida C. Tan, Harold I. Feldman, Alan S. Go (2021). Race, Genetic Ancestry, and Estimating Kidney Function in CKD. New England Journal of Medicine (2022 Top 10 Clinical Research Achievement Awards).

Ke Xu, Jianqiao Wang, Rui Pan, Hansheng Wang (2019). Photographic diary: a new estimation approach to PM 2.5 monitoring. Statistics and Its Interface.

Yong Chen, Jianqiao Wang, Jessica Chubak, Rebecca A Hubbard (2019). Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence. Pharmacoepidemiology and drug safety.